PRME Financial Statements

Balance sheet, income statement, cash flow, and dividends for Prime Medicine Inc (PRME).


$382.99M Market Cap.

As of 03/01/2025 5:00 PM ET (MRY) • Disclaimer

PRME Market Cap. (MRY)


PRME Shares Outstanding (MRY)


PRME Assets (MRY)


Total Assets

$297.51M

Total Liabilities

$144.36M

Total Investments

$7.97M

PRME Income (MRY)


Revenue

$2.98M

Net Income

-$195.88M

Operating Expense

$205.45M

PRME Cash Flow (MRY)


CF Operations

-$122.86M

CF Investing

$68.46M

CF Financing

$195.88M

PRME Dividends (MRY)


Period

Dividends

Yield %

Growth %

Payout Ratio

Coverage Ratio

2024

$0

0%

0%

0%

-

2023

$0

0%

0%

0%

-

2022

$0

0%

0%

0%

-

2021

$0

-

0%

0%

-

2020

$0

-

-

0%

-

PRME Balance Sheet (MRY)


Metric

2024

2023

2022

2021

Total Assets

$297,508,000 (53.47%)

$193,851,000 (-46.20%)

$360,314,000 (19.37%)

$301,856,000 (451.00%)

Assets Current

$211,886,000 (48.20%)

$142,976,000 (-51.80%)

$296,618,000 (9.62%)

$270,579,000 (406.68%)

Assets Non-Current

$85,622,000 (68.30%)

$50,875,000 (-20.13%)

$63,696,000 (103.65%)

$31,277,000 (2164.81%)

Goodwill & Intangible Assets

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Shareholders Equity

$153,149,000 (15.09%)

$133,071,000 (-57.92%)

$316,270,000 (302.43%)

-$156,240,000 (-6782.63%)

Property Plant & Equipment Net

$71,560,000 (95.52%)

$36,600,000 (-24.62%)

$48,554,000 (209.70%)

$15,678,000 (2530.54%)

Cash & Equivalents

$196,538,000 (256.89%)

$55,070,000 (-72.62%)

$201,116,000 (1.29%)

$198,545,000 (436.97%)

Accumulated Other Comprehensive Income

$1,000 (106.67%)

-$15,000 (96.09%)

-$384,000 (-1322.22%)

-$27,000 (0%)

Deferred Revenue

$70,310,000 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Total Investments

$7,966,000 (-90.05%)

$80,091,000 (-24.66%)

$106,301,000 (26.25%)

$84,200,000 (414.89%)

Investments Current

$7,966,000 (-90.05%)

$80,091,000 (-24.66%)

$106,301,000 (26.25%)

$84,200,000 (414.89%)

Investments Non-Current

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Inventory

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Trade & Non-Trade Receivables

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Trade & Non-Trade Payables

$11,351,000 (-41.90%)

$19,537,000 (350.99%)

$4,332,000 (201.88%)

$1,435,000 (474.00%)

Accumulated Retained Earnings (Deficit)

-$687,212,000 (-39.87%)

-$491,330,000 (-67.58%)

-$293,197,000 (-71.08%)

-$171,376,000 (-2751.99%)

Tax Assets

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Tax Liabilities

$0 (0%)

$0 (0%)

$279,000 (-77.55%)

$1,243,000 (-33.42%)

Total Debt

$40,794,000 (199.23%)

$13,633,000 (-52.57%)

$28,745,000 (176.23%)

$10,406,000 (0%)

Debt Current

$3,614,000 (-61.04%)

$9,276,000 (-20.68%)

$11,694,000 (59.41%)

$7,336,000 (0%)

Debt Non-Current

$37,180,000 (753.34%)

$4,357,000 (-74.45%)

$17,051,000 (455.41%)

$3,070,000 (0%)

Total Liabilities

$144,359,000 (137.51%)

$60,780,000 (38.00%)

$44,044,000 (-29.30%)

$62,296,000 (192.35%)

Liabilities Current

$37,961,000 (-32.72%)

$56,423,000 (111.21%)

$26,714,000 (-53.93%)

$57,983,000 (198.24%)

Liabilities Non-Current

$106,398,000 (2342.00%)

$4,357,000 (-74.86%)

$17,330,000 (301.81%)

$4,313,000 (131.01%)

PRME Income Statement (MRY)


Metric

2024

2023

2022

2021

Revenues

$2,983,000 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Cost of Revenue

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Selling General & Administrative Expense

$50,161,000 (15.61%)

$43,387,000 (45.50%)

$29,819,000 (114.16%)

$13,924,000 (340.35%)

Research & Development Expense

$155,289,000 (4.99%)

$147,905,000 (70.54%)

$86,725,000 (22.93%)

$70,550,000 (2267.45%)

Operating Expenses

$205,450,000 (0.32%)

$204,792,000 (75.72%)

$116,544,000 (37.96%)

$84,474,000 (1275.35%)

Interest Expense

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Income Tax Expense

$0 (0%)

-$279,000 (70.57%)

-$948,000 (-95.06%)

-$486,000 (-126.03%)

Net Loss Income from Discontinued Operations

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Consolidated Income

-$195,882,000 (1.14%)

-$198,133,000 (-62.64%)

-$121,821,000 (26.33%)

-$165,367,000 (-4749.47%)

Net Income to Non-Controlling Interests

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income

-$195,882,000 (1.14%)

-$198,133,000 (-62.64%)

-$121,821,000 (26.33%)

-$165,367,000 (-4749.47%)

Preferred Dividends Income Statement Impact

$0 (0%)

$0 (0%)

$20,193,000 (7.68%)

$18,752,000 (1039.94%)

Net Income Common Stock

-$195,882,000 (1.14%)

-$198,133,000 (-39.52%)

-$142,014,000 (22.87%)

-$184,119,000 (-3542.31%)

Weighted Average Shares

$118,600,381 (30.37%)

$90,969,327 (168.42%)

$33,891,264 (161.23%)

$12,973,495 (391.47%)

Weighted Average Shares Diluted

$118,600,381 (30.37%)

$90,969,327 (168.42%)

$33,891,264 (161.23%)

$12,973,495 (391.47%)

Earning Before Interest & Taxes (EBIT)

-$195,882,000 (1.28%)

-$198,412,000 (-61.61%)

-$122,769,000 (25.98%)

-$165,853,000 (-10648.74%)

Gross Profit

$2,983,000 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Operating Income

-$202,467,000 (1.14%)

-$204,792,000 (-75.72%)

-$116,544,000 (-37.96%)

-$84,474,000 (-8963.73%)

PRME Cash Flow Statement (MRY)


Metric

2024

2023

2022

2021

Net Cash Flow from Investing

$68,457,000 (265.86%)

$18,711,000 (139.73%)

-$47,096,000 (36.03%)

-$73,626,000 (-6832.77%)

Net Cash Flow from Financing

$195,876,000 (29804.73%)

$655,000 (-99.64%)

$181,494,000 (-32.60%)

$269,278,000 (670.82%)

Net Cash Flow from Operations

-$122,865,000 (25.72%)

-$165,412,000 (-25.48%)

-$131,827,000 (-286.79%)

-$34,082,000 (-514.75%)

Net Cash Flow / Change in Cash & Cash Equivalents

$141,468,000 (196.87%)

-$146,046,000 (-5780.51%)

$2,571,000 (-98.41%)

$161,570,000 (470.35%)

Net Cash Flow - Business Acquisitions and Disposals

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Cash Flow - Investment Acquisitions and Disposals

$74,751,000 (170.79%)

$27,605,000 (191.00%)

-$30,336,000 (56.02%)

-$68,980,000 (0%)

Capital Expenditure

-$7,294,000 (16.39%)

-$8,724,000 (45.80%)

-$16,095,000 (-287.83%)

-$4,150,000 (-549.45%)

Issuance (Repayment) of Debt Securities

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Issuance (Purchase) of Equity Shares

$189,876,000 (28888.70%)

$655,000 (-99.65%)

$185,536,000 (0%)

$0 (0%)

Payment of Dividends & Other Cash Distributions

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Effect of Exchange Rate Changes on Cash

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Share Based Compensation

$26,068,000 (87.40%)

$13,910,000 (115.36%)

$6,459,000 (269.93%)

$1,746,000 (346.55%)

Depreciation Amortization & Accretion

$18,483,000 (5.97%)

$17,441,000 (45.17%)

$12,014,000 (147.15%)

$4,861,000 (11204.65%)

PRME Financial Metrics (MRY)


Metric

2024

2023

2022

2021

Gross Margin

100.00%

-

-

-

Profit Margin

-6566.60%

-

-

-

EBITDA Margin

-5947.00%

-

-

-

Return on Average Equity (ROAE)

-100.10% (-6.83%)

-93.70% (47.21%)

-177.50% (-174.17%)

239.30%

Return on Average Assets (ROAA)

-65.20% (15.21%)

-76.90% (-79.25%)

-42.90% (58.47%)

-103.30%

Return on Sales (ROS)

-6566.60%

-

-

-

Return on Invested Capital (ROIC)

-105.50% (24.10%)

-139.00% (-22.79%)

-113.20% (81.54%)

-613.10%

Dividend Yield

0% (0%)

0% (0%)

0%

-

Price to Earnings Ratio (P/E)

-1.77 (56.45%)

-4.06 (8.34%)

-4.43

-

Price to Sales Ratio (P/S)

116.1

-

-

-

Price to Book Ratio (P/B)

2.5 (-61.40%)

6.48 (13.47%)

5.71

-

Debt to Equity Ratio (D/E)

0.94 (106.35%)

0.46 (228.78%)

0.14 (134.84%)

-0.4 (-104.38%)

Earnings Per Share (EPS)

-1.65 (24.31%)

-2.18 (47.97%)

-4.19 (70.47%)

-14.19 (-642.93%)

Sales Per Share (SPS)

0.03 (0%)

0 (0%)

0 (0%)

0 (0%)

Free Cash Flow Per Share (FCFPS)

-1.1 (42.69%)

-1.91 (56.15%)

-4.37 (-48.12%)

-2.95 (-25.83%)

Book Value Per Share (BVPS)

1.29 (-11.76%)

1.46 (-84.32%)

9.33 (177.49%)

-12.04 (-1459.26%)

Tangible Assets Book Value Per Share (TABVPS)

2.51 (17.69%)

2.13 (-79.95%)

10.63 (-54.31%)

23.27 (12.11%)

Enterprise Value Over EBIT (EV/EBIT)

-1 (75.00%)

-4 (71.43%)

-14

-

Enterprise Value Over EBITDA (EV/EBITDA)

-1.65 (63.73%)

-4.54 (71.68%)

-16.04

-

Asset Turnover

0.01 (0%)

0 (0%)

0 (0%)

0

Current Ratio

5.58 (120.28%)

2.53 (-77.18%)

11.1 (137.90%)

4.67 (69.89%)

Dividends

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Free Cash Flow (FCF)

-$130,159,000 (25.25%)

-$174,136,000 (-17.72%)

-$147,922,000 (-286.91%)

-$38,232,000 (-518.34%)

Enterprise Value (EV)

$292,198,659 (-64.45%)

$821,879,307 (-53.73%)

$1,776,126,994

-

Earnings Before Tax (EBT)

-$195,882,000 (1.28%)

-$198,412,000 (-61.61%)

-$122,769,000 (25.98%)

-$165,853,000 (-10648.74%)

Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)

-$177,399,000 (1.97%)

-$180,971,000 (-63.40%)

-$110,755,000 (31.20%)

-$160,992,000 (-10632.80%)

Invested Capital

$103,803,000 (8.14%)

$95,991,000 (-40.46%)

$161,229,000 (189.28%)

$55,734,000 (3510.89%)

Working Capital

$173,925,000 (100.95%)

$86,553,000 (-67.93%)

$269,904,000 (26.96%)

$212,596,000 (526.02%)

Tangible Asset Value

$297,508,000 (53.47%)

$193,851,000 (-46.20%)

$360,314,000 (19.37%)

$301,856,000 (451.00%)

Market Capitalization

$382,989,659 (-55.58%)

$862,293,307 (-52.26%)

$1,806,130,994

-

Average Equity

$195,752,000 (-7.44%)

$211,482,750 (164.30%)

$80,015,000 (203.98%)

-$76,951,000

Average Assets

$300,345,000 (16.55%)

$257,701,750 (-22.16%)

$331,085,000 (85.67%)

$178,319,500

Invested Capital Average

$185,609,750 (30.04%)

$142,737,250 (31.58%)

$108,481,500 (301.04%)

$27,050,000

Shares

131,160,842 (34.77%)

97,324,301 (0.12%)

97,208,342

-